Peg Horn | Chief Operating Officer |
Mark Goldsmith | Chairman & Chief Executive Officer |
Steve Kelsey | President of R&D |
Jack Anders | Senior Vice President, Finance and Principal Accounting Officer |
Jonathan Chang | SVB Leerink |
Marc Frahm | Cowen & Company |
Good day, ladies and gentlemen, and welcome to the Revolution Medicines Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast. At this time, all participants are in listen-only mode.
Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions]. Please be advised that today's conference call is being recorded.